Khan Aysha Habib, Jafri Lena, Ahmed Sibtain, Noordin Shahryar
Department of Pathology & Laboratory Medicine, Aga Khan University, Pakistan.
Department of Surgery, Aga Khan University, Pakistan.
Ann Med Surg (Lond). 2018 Mar 29;29:19-25. doi: 10.1016/j.amsu.2018.03.019. eCollection 2018 May.
Despite major advances in osteoporosis diagnosis and treatment, low rates of investigating and treating osteoporosis in patients with fragility fracture are reported in Pakistan. Cost of therapies, time and cost of resources for diagnosis, concerns about medications and lack of clarity regarding the onus of responsibility to undertake this care, are some of the barriers to osteoporosis identification and treatment. Data from our part of the world on osteoporosis as well as on fragility fractures is sparse. This review addresses the current screening and diagnostic strategies for osteoporosis and reviews the existing literature to highlight the issues prevalent in our society on this major public health problem.
尽管在骨质疏松症的诊断和治疗方面取得了重大进展,但据报道,巴基斯坦脆性骨折患者中骨质疏松症的检查和治疗率较低。治疗费用、诊断所需的时间和资源成本、对药物的担忧以及对承担此类护理责任的责任归属缺乏明确认识,都是骨质疏松症识别和治疗的一些障碍。我们所在地区关于骨质疏松症以及脆性骨折的数据很少。本综述阐述了当前骨质疏松症的筛查和诊断策略,并回顾现有文献,以突出我们社会中关于这一重大公共卫生问题的普遍存在的问题。